Antioxidant Enzymes and Weight Gain in Drug-naive First-episode Schizophrenia Patients Treated with Risperidone for 12 Weeks: A Prospective Longitudinal Study

Background: Oxidative stress plays an important role in weight gain induced by antipsychotics in schizophrenia (SCZ). However, little is known about how antioxidant enzymes are involved in weight gain caused by risperidone monotherapy in antipsychotics-naïve first-episode (ANFE) patients with SCZ. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Haixia, Yu, Rui, Gao, Yanan, Li, Xirong, Guan, Xiaoni, Thomas, Kosten, Xiu, Meihong, Zhang, Xiangyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881063/
https://www.ncbi.nlm.nih.gov/pubmed/34544343
http://dx.doi.org/10.2174/1570159X19666210920090547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881063/
https://www.ncbi.nlm.nih.gov/pubmed/34544343
http://dx.doi.org/10.2174/1570159X19666210920090547

Ejemplares similares